M&A Deal Summary |
|
|---|---|
| Date | 2022-11-08 |
| Target | Alcami |
| Sector | Life Science |
| Buyer(s) |
Vistria Group
GHO Capital Partners |
| Sellers(s) |
Madison Dearborn Partners
Ampersand Capital Partners |
| Deal Type | Secondary Buyout |
| Advisor(s) | Morgan Stanley (Financial) Kirkland & Ellis (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
The Vistria Group is a middle-market private equity firm focused on the education, healthcare, and financial services industries. Vistria was formed in 2013 and is based in Chicago, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 26 of 29 |
| Sector (Life Science) | 5 of 5 |
| Type (Secondary Buyout) | 10 of 13 |
| State (North Carolina) | 2 of 2 |
| Country (United States) | 26 of 29 |
| Year (2022) | 7 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-06-28 |
Sandstone Care
Denver, Colorado, United States Sandstone Care is a provider of high-quality care for young people with a variety of behavioral and mental health conditions including depression, anxiety, suicidal tendencies, substance use disorder, or any set of co-occurring conditions. Sandstone Care was founded in 2015 and is based in Denver, Colorado. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-06-15 |
MGT
Tampa, Florida, United States MGT is a provider of social impact and performance improvement solutions for public agencies, philanthropic organizations, and Fortune 500 companies across the U.S. and abroad. The company has expanded its education and technology solutions portfolio with the addition of Davis Demographics, EH&A, Kitamba, Ed Direction, Cira Infotech, Layer 3 Communications, and Step By Step Learning. It provides highly specialized solutions addressing mission-critical client priorities that improve outcomes and helps organizations and communities thrive. MGT was founded in 1975 and is based in Tampa, Florida. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2014 |
| PE ASSETS | 6.0B EUR |
| Size | Mega |
| Type | Sector Focused |
GHO Capital Partners is a private investment firm focused on the healthcare sector. The Firm will consider opportunities throughout Europe and seeks well-established, profitable businesses that have the potential to deliver a combination of double-digit top line growth, significant efficiency gains and international expansion. GHO Capital Partners was established in 2014 and is based in London, England.
| DEAL STATS | # |
|---|---|
| Overall | 18 of 20 |
| Sector (Life Science) | 12 of 14 |
| Type (Secondary Buyout) | 10 of 11 |
| State (North Carolina) | 3 of 3 |
| Country (United States) | 8 of 9 |
| Year (2022) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-12-09 |
Biocare Medical
Pacheco, California, United States Biocare Medical is a provider of immunohistochemistry (IHC) instrumentation, as well as a full range of reagents for IHC and molecular testing. The company engages in IHC and molecular diagnostic reagents, including simultaneous Multiplex IHC tests that provide increased confidence at critical diagnostic decision points, positively influencing patient therapy while accelerating turnaround time. Biocare Medical was founded in 1997 and is based in Pacheco, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-07-01 |
FairJourney Biologics
Porto, Portugal FairJourney Biologics is a biologics CRO, providing integrated services across antibody discovery, engineering, and production to global biopharma. The company operates a flexible, customer-oriented ‘one-stop-shop’ approach to biologics development focused on quality, reliability, and partnership. FairJourney Biologics was founded in 2012 and is based in Porto, Portugal. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1992 |
| PE ASSETS | 28.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Madison Dearborn Partners (MDP) is a large private equity firm that targets buyouts of private or publicly held companies, divestitures of larger companies, recapitalizations of family-owned or closely-held companies, acquisition-oriented financings, and financings to fund internal growth. MDP's target investment size is $100 to $600 million in buyout oriented transactions and $100 to $400 million in growth capital commitments. Areas of interest include basic industries (natural resources, chemicals, energy and power, automotive, building products, food, metals and mining, refining, paper, packaging and forest products, and general manufacturing), as well as communications, consumer products/services, financial services, and healthcare. Madison Dearborn Partners was formed in 1992 and is based in Chicago, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 68 of 74 |
| Sector (Life Science) | 2 of 2 |
| Type (Secondary Buyout) | 13 of 14 |
| State (North Carolina) | 1 of 1 |
| Country (United States) | 60 of 66 |
| Year (2022) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-08-01 |
EVO
Atlanta, Georgia, United States EVO is a payment technology and services provider that offers an array of innovative, reliable, and secure payment solutions to merchants across the globe EVO was founded in 1989 and is based in Atlanta, Georgia. |
Sell | $4.0B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-12-19 |
Wilmington Trust - CIT Business
Wilmington, Delaware, United States Wilmington Trust - CIT Business is a provider of third-party trustee and administrative services to asset managers and the employer-sponsored retirement market. Wilmington Trust's CIT Business is based in Wilmington, Delaware. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 2.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 54 of 55 |
| Sector (Life Science) | 24 of 25 |
| Type (Secondary Buyout) | 6 of 6 |
| State (North Carolina) | 4 of 4 |
| Country (United States) | 51 of 51 |
| Year (2022) | 7 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-10-03 |
GenDx
Utrecht, Netherlands GenDx is a Dutch company specializing in Molecular Diagnostics, focused on the development, production, and sales of innovative assays and analysis software for transplantation and companion diagnostics. GenDx specializes in HLA sequencing-based typing strategies and offers reagents and software for both Sanger and NGS approaches. GenDx was founded in 2005 and is based in Utrecht, Netherlands. |
Sell | €135M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-05-02 |
P95
Leuven, Belgium P95 is a global provider of clinical and epidemiology research solutions with a specialty focus on vaccines and infectious diseases. P95 offers a wide range of solutions including phase I-IV clinical studies, epidemiology, and RWE studies, in addition to scientific and clinical development consulting. It provides end-to-end services including study start-up, clinical monitoring, sample management, medical monitoring and pharmacovigilance, qualitative research, medical writing, data management, biostatistics, and IT. P95 was founded in 2011 and is based in Leuven, Belgium. |
Buy | - |
